Nathalie Adda, Senior VP & Chief Medical Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 18,994 shares at $85.02 ($1.6M) on 2021-11-01, disclosed to the SEC on 2021-11-02.
Open-market sale of $1.6M ENTA by Senior VP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.31 | 1,952 | $165K | 10.2% |
| 2 | $84.31 | 1,952 | $165K | 10.2% |
| 3 | $85.02 | 7,495 | $637K | 39.5% |
| 4 | $85.02 | 7,495 | $637K | 39.5% |
| 5 | $86.21 | 100 | $9K | 0.5% |
| Total | $84.88 avg | 18,994 |
| $1.6M |
| 100% |
| Filing → |
| ENTA | SELL | 2022-01-13 | $1.8M | — | Filing → |
| ENTA | SELL | 2021-12-03 | $1.9M | — | Filing → |
| ENTA | SELL | 2021-10-13 | $2.5M | — | Filing → |